This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

More Than 1,000 First Time Patients Screened On National Colon Cancer Screening Day

NASHVILLE, Tenn., March 9, 2012  /PRNewswire/ -- achieved its goal of screening 1,000 "first-timers" for colon cancer on the first National Colon Cancer Screening Day on Thursday, March 8, 2012.

As part of Colorectal Cancer Awareness Month, National Colon Cancer Screening Day was created to urge all first-time patients to complete or schedule a colonoscopy on March 8, and that goal has been exceeded. More than 1,000 patients accepted the challenge and were screened for colon cancer by affiliated physicians. physicians perform approximately 1 in 10 screening colonoscopies in the nation, so the organization's sincere hope is that the number of screenings and appointments scheduled in the United States was ten-fold on National Colon Cancer Screening Day.

A new study published in the New England Journal of Medicine provides what researchers are calling the best evidence yet that colonoscopies prevent people from dying from colon cancer.  The study shows that the colon cancer death rate was cut by more than half in those who had a colonoscopy.

"Almost 40 percent of Americans at risk for colon cancer are not getting screened, and we must change that," said Dr. John Popp, Medical Advisor,  "We believe our first National Screening Day is a strong step in the right direction.  And while we have promoted this one day for screenings, our larger mission is to make every day a 'national screening day' in hopes of saving more lives."

Those who are at a higher risk for colon cancer include: anyone over the age of 50, African- Americans who are 45 years of age and over and those who have a family history of polyps or colon cancer.

A colonoscopy allows doctors to find and remove precancerous polyps before they develop into cancer, making a colonoscopy the only test that allows both diagnosis and treatment at the same time.  Colonoscopy can also find cancer at its earliest stage, when treatment works best. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs